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Summary 
REK7 is an Eph-related tyrosine kinase receptor ex- 
pressed exclusively in the nervous system, predomi- 
nantly in hippocampus and cortex. A soluble REK7- 
IgG fusion protein, produced to analyze the biological 
role of REK7, prevents axon bundling in cocultures of 
cortical neurons with astrocytes, a model of late stage 
nervous system development and differentiation. Us- 
ing REK7-1gG as an affinity reagent, we purified and 
cloned a novel REK7 ligand called AL-1, a GPl-linked 
protein homologous to other members of an emerging 
ligand family. Membrane attachment of AL-1 appears 
necessary for receptor activation, since REK7 on corti- 
cal neurons is efficiently activated by transfected cells 
expressing GPl-linked AL-1, but not by soluble AL-1. 
Consistent with this, soluble AL-1 blocks axon bundling. 
Our findings, together with the observation that both 
molecules are expressed in the brain, suggest a role 
in the formation of neuronal pathways, a crucial fea- 
ture of nervous system development and regener- 
ation. 
Introduction 
Signaling by tyrosine kinase receptors has been well estab- 
lished as an important mechanism for regulating growth 
and differentiation of cells (reviewed by Schlessinger and 
UIIrich, 1992; UIIrich and Schlessinger, 1990). Tyrosine 
kinase receptors are prevalent throughout the nervous 
system and are known to have a crucial role in both the 
development and maintenance of nerve cells (Snider, 
1994). Tyrosine kinase receptors can be classified into 
families based on their structural motifs (Fantl et al., 1993). 
The largest of these is the Eph family (reviewed by Tuzi and 
Gullick, 1994), comprising at least 13 distinct members. 
Many Eph family members are expressed exclusively or 
predominantly in the nervous system, suggesting they 
have specific functions there. The expression patterns that 
have been observed for some Eph family members sug- 
gest a role in embryogenesis (e.g., in pattern formation; 
Becker at al., 1994). However, no specific biological func- 
tions have been elucidated for any member of this largest 
tyrosine kinase receptor family. 
*These authors contributed equally to this work. 
During a recent search to find new tyrosine kinase recep- 
tors and ligands that function in the nervous system, we 
isolated an Eph family receptor, REK7, that appears to be 
the rat homolog of CEK7 (Sajjadi and Pasquale, 1993) and 
is essentially identical to EHK-1 (Maisonpierre t al., 1993) 
and BSK (Zhou et al., 1994). REK7 is expressed exclu- 
sively in the nervous system in both the embryo and adult. 
In the adult rat brain, the expression levels are highest in 
the hippocampus and cortex. (1. W. C., unpublished data; 
Maisonpierre et al., 1993; Zhou et al., 1994). To probe the 
biological function of this receptor, we produced a REK7- 
IgG fusion protein and tested its effects in cocultures of 
primary cortical neurons plated on confluent cortical 
astrocytes, a cell culture system that promotes the forma- 
tion of long axon bundles. In addition, we cloned a novel 
ligand for REK7, named AL-1. We furnish evidence sug- 
gesting that REK7 and AL-1 play a crucial role in axon 
fasciculation, thus providing an indication of a specific bio- 
logical function for an Eph-related tyrosine kinase re- 
ceptor. 
Results and Discussion 
REK7-1gG Blocks Axon Bundle Formation 
We identified REK7 using a polymerase chain reaction 
(PCR)-based strategy (Raz et al., 1991) to screen for novel 
tyrosine kinase genes expressed in the hippocampus. A 
full-length cDNA encoding REK7 was subsequently iso- 
lated from a rat hippocarnpal cDNA library and encodes 
an Eph-related tyrosine kinase receptor that appears to 
be the rat homolog of CEK7 (Sajjadi and Pasquale, 1993) 
and that is essentially identical to EHK-1 (Maisonpierre et 
al., 1993) and BSK (Zhou et al., 1994). Our rek7 cDNA 
corresponds to the splice variant of ehk-1 lacking the first 
of two tandem fibronectin type-Ill domains. Since in situ 
hybridization analysis revealed high levels of REK7 ex- 
pression in neurons of the hippocampus and cortex (un- 
published data; Maisonpierre et al., 1993; Zhou et al., 
1994), we tested the effect of blocking REK7 activity in 
cocultures of cortical neurons on astrocytes, using a solu- 
ble REK7-1gG fusion protein containing the extracellular 
domain of REK7. In these cultures, differentiation of neu- 
rons reaches an advanced stage analogous to late devel- 
opment in the brain, when neu ral pathways and fiber tracts 
are laid down. One manifestation of this is the formation 
of large axon bundles. These fiber bundles can be stained 
with an antibody against tau, a protein found in axons and, 
to a lesser extent, in dendrites (Binder et al., 1985), but not 
with an antibody against microtubule-associated protein 2 
(MAP2), a dendritic marker (Caceres et al., 1986; Dotti 
et al., 1987) (Figures 1A and 1C). This indicates that the 
bundles are composed of axons. The addition of REK7- 
IgG to the culture medium completely prevented the for- 
mation of axon bundles, while having little or no effect on 
dendritic processes (Figures 1B and 1D). In contrast, a 
number of other receptor-lgG fusion proteins tested (e.g., 
CD4-1gG [Capon et al., 1989], TrkA-IgG [Shelton et al., 
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Figure 1. REKT-IgG Blocks the Formation of Axon Bundles in Cocultures of Primary Cortical Neurons on Astrocytes 
Cultures were grown as described in Experimental Procedures under control conditions (A and C) or in the presence of REK7-1gG (B and D) and 
stained with anti-tau antibody, a marker for axons (A and B) or with anti-MAP2 antibody, a marker for dendrites (C and D). To show that REK7- 
IgG does not inhibit axon outgrowth, cortical neurons were plated at low density on astrocytes (50,000 neurons per 35 mm well), to allow visualization 
of individual axons, and cultured for 4 days in the presence of either REK7-1gG (F) or a control protein, CD4-1gG (E). The cells were fixed and 
stained with an anti-neurofilament antibody that stains both axons and dendrites. Under these low density conditions, the cortical neurons do not 
form axon bundles, although they elaborate long axons, sim~ar to higher density cultures. 
1995], and the Eph-related HTK-IgG [Bennett et al., 1994]) 
had no effect on axon bundling (data not shown). 
To determine whether the absence of axon bundles in 
REK7-1gG-treated cultures is due to an inhibition of the 
bundling process per se versus a generalized inhibition 
of axon outgrowth or reduction in neuron survival, we cul- 
tured cortical neurons at low density on astrocytes and 
measured the axon length per neuron. We observed no 
significant difference in either the density of process- 
bearing cells or the length of individual axons in cultures 
treated with REK7-1gG versus a control protein, CD4-1gG 
(Figures 1E and 1F; Table 1), indicating that REK7-1gG 
is not an inhibitor of axon outgrowth. Rather, these results 
suggest a role for REK7 in axon fasciculation, a crucial 
process during nervous system development and regener- 
ation. In support of this notion, we stained the differenti- 
ated cocultures with antibodies against REK7 and a re- 
lated Eph family receptor, SEK1 (Gilardi-Hebenstreit et 
al., 1992). We detected expression of REK7, but not SEK1, 
on the surface of the axonal fibres within the bundles (Fig- 
ure 2). 
Table 1. Effect of REK7-1gG on Axon Outgrowth 
CD4-igG REK7-1gG 
Density of process-bearing cells 100.6 _ 4.1 91.6 ± 4.1 
(cells/ram 2) 
Axon length (p.m) 262 ± 21 257 _ 23 
Cortical neurons were plated on astrocytes at low density (50,000.cells 
per 35 mm well) to enable visualization and measurement of individual 
axons. The cells were cultured for 4 days in the presence of either 
REK7-1gG or a control protein, CD4-1gG, and then fixed and stained 
with antibodies to neurofilament or MAP2. The longest anti-neurofila- 
ment-stained processes, representing axons, were measured. 
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Figure 2. REK7 Is Expressed on the Surface of the Axon Fibers 
The cocultures were fixed and stained by indirect immunofluorescence, either without the addition of a primary antibody (A) or with rabbit antibodies 
against SEK1 (B) or REK7 (C and D; showing two different views of the same culture), followed by fluorescein-conjugated anti-rabbit IgG F(ab')2 
fragment. Arrows indicate axon fibers showing REK7 expression. 
Purification of a Ligand for REK7 
To isolate the putative REK7 ligand, we used REK7-1gG 
to screen cultured cell lines for cell surface expression of 
a REK7-binding activity. Analysis by flow cytometry identi- 
fied the human breast carcinoma line, BT20 (Figure 3A), 
and HeLa (data not shown). Incubation of BT20 cells with 
phosphatidylinositol-specific phospholipase C (PIPLC) 
significantly reduced the relative cell fluorescence, a mea- 
sure of the level of REK7-binding activity on the cell sur- 
face, from 571 to 128, suggesting that this ligand is linked 
with glycophosphatidylinositol (GPI; Figure 3A). Competi- 
tion binding of 1251-labeled REK7-1gG to BT20 cells and 
Scatchard analysis demonstrated a single high affinity 
binding interaction with a dissociation constant (KD) of 1 
nM and a density of 8000 REK7-binding sites per cell. 
Knowing that many GPl-linked proteins undergo signifi- 
cant shedding from the cell surface (Metz et al., 1994), 
we collected conditioned medium from BT20 cells and 
purified the REK7 ligand by affinity chromatography on a 
column of immobilized REK7-1gG. Analysis of the eluted 
fractions by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) revealed the presence of three proteins with 
Mr values of approximately 28,000, 27,000, and 25,000 
(-28K, -27K, and -25K) that were absent in fractions 
eluted by similar treatment of a CD4-1gG precolumn (Fig- 
ure 3B). These proteins were electroblotted and subjected 
to N-terminal sequence analysis. The -27K  protein re- 
vealed the sequence NH2-DRYAVYWNSSNPRFQRG- 
DYHIDVXlNDYXD. The - 28K and -25K  proteins had 
blocked N-termini. Sequence analysis of peptides gener- 
ated by in situ cyanogen bromide cleavage or in situ diges- 
tion with Lys-C endopeptidase (Wong et al., 1993; Henzel 
et al., 1990) revealed that the - 28K, - 27K, and -25K  
proteins are related. A Lys-C endopeptide derived from the 
28K protein had a sequence identical to the N-terminus of 
the -27K  protein, but containing 3 additional N-terminal 
residues, AVA. These data, together with the peptide map 
obtained from the Lys-C digestions, suggest that proteo- 
lytic processing of the -28K  protein at either the N- or 
C-terminus produces the - 27K or - 25K species, respec- 
tively. The following internal sequences were obtained for 
this ligand, named AL-I: M/KTIGVHDRVFDVNDKVEN- 
XLEPA, VNFDGYSAXDHTSKGFKRXEXNR, FQLFTPFS- 
LGXEXRXGREXFYISXAIP, and K/RWECNRP. 
cDNA Cloning of the REK7 Ligand, AL-1 
Based on the protein sequence determined for AL-1, we 
synthesized three degenerate oligonucleotide primer 
pools, which were used to amplify BT20 cell cDNA by PCR. 
Two fragments having the expected sizes (180 or 135 bp) 
were sequenced and predicted an amino acid sequence 
that matched that obtained by protein sequencing. The 
180 bp fragment was used to screen a human fetal brain 
cDNA library (2 x 106 clones). Two positive clones, having 
inserts of 1.0 or 1.6 kb, respectively, were sequenced. 
The AL-1 cDNA (Figure 4A) contains a presumed initia- 
tion codon at nucleotide position 323, within a consensus 
sequence favorable for eukaryotic translation initiation 
(Kozak, 1986), followed by an open reading frame pre- 
dicting a primary translation product of 228 amino acids. 
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Figure 3. Identification f a Source for and Purification of a REK7 
Ligand 
(A) Expression of a REK7-binding activity on the surface of BT20 cells 
and its release by PIPLC. BT20 cells were incubated for 2 hr at 4°C 
in DMEM medium without (top) or with (bottom) purified PIPLC (4 p.g/ 
ml). Cells were analyzed by indirect immunofluoreecence and flow 
cytometry after treatment with REK7-1gG (solid lines) or human IgG, 
Fc fragment (broken lines), followed by biotin-conjugated Fc fragment- 
specific anti-human igG and phycoerythrin-conjugated s reptavidin. 
(B) SDS-PAGE analysis of the purification f AL-1 by affinity chroma- 
tography. Lane 1, molecular size standards; lane 2, column load; lane 
3, column flow-through; lane 4, first PBS wash; lane 5, second PBS 
wash; lane 6, first pH 3.0 wash; lane 7, second pH 3.0 wash; lane 8, 
third pH 3.0 wash (15 rain incubation). Lanes 9-11, CD4-1gG precol- 
umn: lane 9, molecular size standards; lane 10, second pH 3.0 wash; 
lane 11, third pH 3.0 wash (15 min incubation). Gels were stained with 
silver. Note the specific elution of a major - 28K band and minor - 27K 
and -25K bands in lane 8. 
Hydropathy analysis indicates that the first 18-20 amino 
acids are hydr~ophobic, presumably representing a signal 
peptide for secretion. Computer analysis (von Heijne, 
1983) predicts the most favorable signal peptidase cleav- 
age site to lie between residues 20 and 21, which would 
generate a mature polypeptide beginning with the se- 
quence QDP. N-terminal glutamine residues are known 
to cyclize to form pyroglutamate (pyrrolidonecarboxylic 
acid), which would account for the blocked N-terminus of 
the -28K  species purified from BT20 cells. Digestion with 
pyroglupeptidase followed by N-terminal sequencing veri- 
fled that this is the case. The - 27K species, which begins 
with the sequence DRY, thus lacks 9 N-terminal residues, 
consistent with the observed molecular mass difference 
of - 1 kDa. The C-terminus of AL-1 contains a favorable 
sequence for G PI addition (Moran and Caras, 1991), com- 
prising a 15 residue C-terminal hydrophobic domain pre- 
ceded by a potential cleavage/attachment si e (Moran and 
Caras, 1994) for the anchor at Asn-103. This is consistent 
with our observation that AL-1 expressed on the surface 
of BT20 cells is GPI anchored, as is the ECK ligand, B61 
(Bartley et al., 1994). 
Comparison of the AL-1 sequence with the GenBank 
sequence database indicates that AL-1 is a new member 
of an emerging ligand family (Figure 4B). ELF-1 (Cheng 
and Flanagan, 1994), a ligand for the Eph-related recep- 
tors HEK and SEK, is the most closely related family mem- 
ber (showing 50.5% identity with AL-1), followed by B61 
(showing 42.9% similarity). EHK1-L (Davis et al., 1994), 
reportedly a ligand for EHK-1/REK7, is only 41.4% identi- 
cal to AL-1. This raises the possibility that there may be 
more than one ligand for REK7, as is the case for the 
neurotrophin receptor TrkB, which binds both brain- 
derived neurotrophic factor and neurotrophin-4/5 (Ip et al., 
1993). AL-1 shows lower homology (28.4%) with the extra- 
cellular domain of the transmembrane ligand, LERK2 
(Beckmann et al., 1994). 
Express ion  o f  AL-1 
Northern blot analysis revealed two AL-1 transcripts of 
-7 .4  and 6 kb, expressed in brain, heart, placenta, lung, 
and kidney (Figure 5A). This is in contrast to the apparent 
lack of expression of rek7 in nonneural tissues (Maison- 
pierre et al., 1993; I. W. C., unpublished ata). Within the 
brain, these same two transcripts were detectable in all 
regions examined (Figure 5B), indicating that, in contrast 
to the more restricted distribution of REK7, AL-1 is widely 
distributed throughout he brain. 
To demonstrate AL-1 expression in our cortical neuron- 
astrocyte cocultures and to determine where it is ex- 
pressed, we analyzed RNA from both cortical neurons and 
astrocytes by reverse transcription-PCR (RT-PCR; Fig- 
ure 5C). A DNA fragment of the predicted size, hybridizing 
to an AL-1 probe, could be amplified using RNA from 
astrocytes or, to a lesser extent, from embryonic cortical 
neurons. Comparison of the amplified AL-1 fragment with 
that of a coamplified reference mRNA, glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH; Fort et al., 1985), in- 
dicates that the level of AL-1 expression is significantly 
higher in astrocytes compared with neurons. In agreement 
with this, indirect immunofluorescent staining of the cocul- 
tures with REK7-1gG detected a punctate staining charac- 
teristic of GPI-anchored proteins on astrocyte cell mem- 
branes but not on neurons (Figure 6). Together, these data 
suggest that the bulk of the AL-1 expressed in this system 
is on astrocytes rather than on neurons. 
Act ivat ion  of  REK7 by AL-1  
To determine whether AL-1 can activate as well as bind 
to REK7, we analyzed cultured primary cortical neurons by 
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Figure 4. AL-1 Sequence 
(A) Nucleotide and deduced amino acid se- 
quences of AL-1. The N-terminus of the mature 
protein is indicated by a right arrow. The under- 
lined sequence corresponds to the sequences 
obtained by protein sequencing of the purified 
BT20 cell-derived AL-I. The shaded boxes in- 
dicate ~tential N-glycosylation sites. The ~xed 
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sequence shows the C-terminal hydrophobic domain, and a potential cleavage/attachment site for GPI addition is indicated by an upward arrow. 
(B) Comparison of the AL-1 sequence with that of ELF-1 (Cheng and Flanagan, 1994), B61 (Bartley et al., 1994), EHK1-L (Davis et al., 1994), and 
the extracellular domain of LERK2 (Beckmann et al., 1994). Identical amino acids are boxed, and gaps introduced for optimal alignment are 
indicated by dashes. Shaded areas highlight conserved cysteine residues. 
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immunoprecipitation and immunoblotting with anti-REK7 
and anti-phosphotyrosine antibodies. Membrane-bound 
AL-1 transiently expressed on the surface of transfected 
293 cells (Figure 7A, upper panel) strongly activated en- 
dogenous REK7 expressed in cortical neurons, as indi- 
cated by autophosphorylation of the 135K REK7 polypep- 
tide (Figure 7B, lower panel). In contrast, purified soluble 
AL-1 only weakly stimulated tyrosine autophosphorylation 
of REK7 (-2-fold). These data confirm the presence of 
REK7 in cortical neurons, indicate that AL-1 is an activat- 
ing ligand, and demonstrate that membrane attachment 
is required for maximal receptor activation, as has been 
Figure 5. Expression of AL-1 
(A and B) Northern blot analysis of various human tissues (A) or adult 
human brain regions (B), probed with a 1.6 kb AL-1 probe. 
(C) RT-PCR detection of AL-1 expression in cortical neurons and 
astrocytes (left, 1.5% agarose gel stained with SYBR green I [Molecu- 
lar Probes, Inc]; right, nitrocellulose blot probed with an AL-1 probe. 
GAPDH was coamplified with AL-1 as an internal standard. HeLa cell- 
derived RNA is included as a positive control; no RNA, as a negative 
control. Additional controls omitting reverse transcriptase were nega- 
tive (data not shown). Longer exposures of the blot (data not shown) 
indicate unequivocally that AL-1 can be amplified from cortical neuron- 
derived RNA. The cortical neurons were from E17 rats and were cul- 
tured for 4 days without astrocytes. 
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Figure 6. Detection of AL-1 on the Surface of Astrocytes by Indirect Immunofluorescence using REK7-igG 
(A, C, and E) Fluorescein fluorescence; (B, D, and F) phase contrast. HeLa cells (A and B) or cocultures of cortical neurons on astrocytes (C and 
D) were stained with REK7-1gG; (E) and (F) show cocultures tained with secondary antibodies but omitting REK7-1gG. 
seen with other members of this ligand family (Davis et 
al., 1994). 
Soluble AL-1 Is an Antagonist of Axon Bundling 
Since soluble AL-1 binds to but does not efficiently activate 
REK7, we postulated that soluble AL-1 might act as an 
antagonist of RE K7 receptor activity and might block axon 
fasciculation in our cell culture system. This is indeed the 
case. The addition of soluble AL-1 to the culture medium 
of cortical neuron-astrecyte cocultures specifically pre- 
vented the formation of axon bundles, as does REK7-1gG 
(Figure 7B). Together with the observations that AL-1 is 
expressed in the cocultures (predominantly on astrocytes), 
that REK7 is expressed on both the axons fibers and cell 
bodies of the cortical neurons, and that AL-1 can activate 
REK7, this result further implicates AL-1 and REK7 as 
the molecules involved in axon bundling whose action is 
inhibited by REK7-1gG. However, there might also be 
other targets for REK7-1gG (e.g., EHK1-L) that we cannot 
at present rule out. 
We also tested the effect on axon bundle formation of the 
anti-REK7 and anti-SEK antibodies, added to the culture 
medium at 200 t~g/ml. Neither reagent had any apparent 
effect on axon bundling in these cultures (data not shown). 
Since the anti-REK7 antibodies bind to the axon fibers 
but fail to block bundle formation, we conclude that mere 
binding to axons is not sufficient to interfere with the 
bundling process. This observation strengthens the argu- 
ment that the inhibitory effects of REK7-1gG and soluble 
AL-1 are due to a specific inhibition of REK7 function. 
Our findings are summarized in the schematic drawing 
shown in Figure 8. Implicit in this model is the suggestion 
that the role of REK7 in axon fasciculation is probably 
indirect; i.e., our model suggests that REK7 and AL-1 do 
not themselves function as adhesion molecules but rather 
may be involved in regulating the fasciculation process. 
We speculate that activation of REK7 expressed on the 
neurons, by AL-1 expressed on the astrocytes, might acti- 
vate a signaling pathway that promotes fasciculation, e.g., 
by up-regulating or activating adhesion molecules. This 
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Figure 7. REK7 Activation and Effects of Soluble AL-1 
(A) Activation of REK7 by soluble and membrane-bound AL-1. The upper panel shows that 293 cells, transiently transfected with an AL-1 cDNA, 
express AL-1. Shown are mock-transfected or AL-l-transfected 293 cells, incubated with REK7-1gG and analyzed by FACS. Lower panel, Western 
immunoblot analysis of REK7 phosphorylation induced by AL-1. Primary cortical neurons were incubated with or without purified soluble AL-1 as 
indicated or with mock-transfected or AL-l-transfected 293 cells as indicated, for 10 min at 37°C. Lysates were immunoprecipitated with an 
anti-REK7 antibody, electroblotted, and probed with an anti-phosphotyrosine antibody. Cortical neurons were from cerebral cortex of E16 r ts and 
were cultured for 4 days at low density (5 x 10 ~ cells per 15 cm dish) prior to stimulation with AL-1. 
(B) Soluble AL-1 blocks the formation of axon bundles in cocultures of primary cortical neurons on astrocytes. Cultures were grown for 7 days in 
the presence of a control protein, CD4-1gG, or soluble AL-1 as indicated, then fixed and stained with an anti-neurofilament antibody. Soluble AL-1 
was purified from the conditioned medium of cells expressing GPl-linked AL-1. 
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REK7 AL-1 
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Figure 8. Schematic Diagram of REK7-AL-1 Interactions Involved in 
Axon Fasciculation 
model is compatible with the current view that astrocytes 
play an important role during development of the CNS, 
where they are thought to provide a substratum and tro- 
phic support for growing axons (Hatten et al., 1990). The 
idea that a tyrosine kinase is required for axon fascicula- 
tion is new and provocative. Neurons in the developing 
or regenerating nervous system presumably require two 
types of factors, those that promote growth and survival 
and those that provide spatial or directional guidance in 
the establishment of neuronal pathways (Tessier-Lavigne, 
1994). Tyrosine kinases are known to play a well- 
established role in the former but have not previously been 
shown to participate in the latter. Our findings, combined 
with the observation that both REK7 and AL-1 are ex- 
pressed in the brain, suggest a role in the formation of 
neuronal pathways, a crucial feature of both development 
and regeneration in the nervous system. 
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Experimental Procedures 
Primary Cultures and Immunostaining 
Astrocyte Cultures 
Cerebral cortex from postnatal day 2 (P2) Wistar rat pups was dissoci- 
ated, and the cells were grown in DMEM/F12 with 10o/o fetal bovine 
serum, 15 mM HEPES (pH 7,4). Confluent cultures were shaken at 
37°C for 24 hr to obtain purified astrocytes (McCarthy and de Vellis, 
1980). Astrocyte cultures were trypsinized, replated, and grown to 
con fluency. 
Cocultures 
Cerebral cortex of embryonic day 16 (E16) rats was dissociated, and 
4 x 105 cells were plated onto 35 mm dishes containing astrocytes 
that had been pretreated for 6 hr with or without protein A-purified 
REK7-1gG or control proteins (30 p,g/ml), or with soluble AL-1 (1-10 p.g/ 
ml). Cultures were grown for 4-7 days in a defined medium (Peterson et 
al., 1989) in the presence or absence of REK7-1gG and then fixed for 
15 rain with 4o/0 paraformaldehyde in 0.1 M sodium phosphate buffer 
(pH 7.4). Fixed cultures were incubated with monoclonal antibodies 
against tau-1, MAP2 (both from Boehringer Manheim, Indianapolis, 
IN), or neurofilament (200 kDa; Chemicon, Temecula, CA). Bound 
antibody was visualized using the HRP-ABC method and the VIP sub- 
strate kit (Vector, Burlingame, CA). 
Indirect Immunofluorescence 
For detection of REK7, fixed cultures were treated with rabbit anti- 
REK7 IgG (20 p_g/ml), followed by fluorescein-conjugated goat anti- 
rabbit IgG (Cappel Laboratories). For detection of AL-1, fixed cultures 
were treated with REK7-1gG (10 p.g/ml), followed by biotin-conjugated 
Fc fragment-specific anti-human IgG and fluorescein-conjugated 
streptavidin (Jackson ImmunoResearch Laboratories, West Grove, PA). 
Flow Cytometry 
Cells were analyzed by indirect immunofluorescence and flow cytome- 
try after treatment with REK7-1gG or human IgG, Fc fragment, followed 
by biotin-conjugated Fc fragment-specific anti-human IgG and phy- 
coerythrin-conjugated streptavidin (Jackson ImmunoResearch). The 
fluorescence intensity was measured on a FACSCAN flow cytometer 
(Becton Dickinson Advanced Cellular Biology, San Jose, CA). 
Protein Purification and Protein Sequence Determination 
Conditioned medium from BT20 cells (12 liters) was concentrated 60- 
fold and loaded onto a 2 ml CD4-1gG-protein A agarose precolumn 
and a 1 ml REK7-1gG affinity column linked in tandem, at 4°C. The 
two columns were then separated, washed with 10 column volumes 
of PBS, and eluted with four washes of 100 mM sodium citrate (pH 
3.0). The first two elutions were allowed to flow rapidly through the 
column, whereas the last two were left on the column for 15 rain before 
collection. The eluted fractions were neutralized to pH 7.4 with 50 mM 
potassium phosphate and analyzed by SDS-PAGE on 14% gels. The 
-25K-28K bands specifically eluted from the REK7 affinity column 
were separated by SDS-PAGE on a 4%-20% gel, electroblotted onto 
a Millipore PSQ membrane (Matsudaira, 1987), and subjected to Ed- 
man protein sequence analysis (Henzel et al., 1987). 
PCR, cDNA Cloning, DNA Sequencing, and Northern Analysis 
Based on the protein sequence obtained from AL-1 purified from 
BT20 cells, two degenerate PCR primer pools were synthesized: 
5'-CCCTCGAGGTCGACGAT/CC/AGITAC/TGCIGT NG/C/-I-IAC/TT- 
GGAA and 5'-CCGCGGTGCGGCCGCTCTAGAGIATAICCG/ATCG/ 
AAAG/ATTC/T/A/GACCAT. Reverse-transcribed cDNA from BT20 
cells was used as the template for PCR (Saiki et al., 1988) in a reaction 
volume of 50 p_l, containing 10 mM Tds (pH 8.3), 50 mM KCI, 1.5 mM 
MgCI2, 0.1% gelatin, 200 I~M dNTPs, 1 p.M of each primer pool, and 
2.5 U of Taq polymerase. Initial template denaturation was at 80°C 
for 5 rain, followed by 30 cycles of 30 s at 94°C, 1 min at 55°C, and 
1 rain at 72°C. The final cycle was allowed to extend for 10 rain at 
72oC. An -186 bp product was obtained and subcloned into pBlue- 
script KS(+), and two clones were sequenced. A 180 bp Sali-Xbal 
fragment was isolated from one of these clones and used to screen 
a human fetal brain cDNA library in Lambda ZAP (Stretagene, La Jolla, 
CA) under high stringency conditions. Plasmids containing the inserts 
of positive clones were recovered using the ZAP Express Vector Exci- 
sion system (Stratagene) according to the manufacturer's instructions. 
Two independent clones were sequenced on both strands by standard 
fluorescent dye terminator and dye primer methods on an ABI373 
automated sequencer. The full-length cDNA was cloned into a mam- 
malian expression vector containing the cytomegalovirus enhancer/ 
promoter and an SV40 polyadenylation sequence (Eaton et al., 1986). 
Northern blots containing -2  p.g of poly(A) + RNA per lane were pur- 
chased from Clontech. The membranes were hybridized with the 1.6 
kb AL-1 insert labeled with [~P]dCTP and [~P]dATP by random hexa- 
nucleotide priming (Feinberg and Vogelstein, 1983), and the blots were 
washed at 65°C in 0.1 x SSC, 0.1o/o SDS. 
For the detection of AL-1 by RT-PCR, reactions were essentially 
as described above, but employing 35 cycles of 94°C for 1 min, 45°C 
for 1.5 rain, and 72 °C for 2 rain. A single 5' primer (5'-AGCAACCCCAG- 
ATTCCAGAGG) was used with one of two 3' primers (5:'I-I'CTACT- 
TTGTCGTTAACATCG or 5'-GAAAACACGATCATGAACACC). 
Receptor Phosphorylation 
HEK 293 cells were transfected with an AL-1 expression plasmid using 
the calcium phosphate coprecipitation method (Simonsen and Levin- 
son, 1983). Primary cortical neurons from E16 rats were plated at a 
density of 5 x 106 cells per 15 cm dish and cultured for 4 days. These 
cells were then treated with purified soluble AL-1 (0.1-1 p_g/ml) or 293 
cells expressing membrane-bound AL-1 for 10 rain at 37°C. Immuno- 
precipitation with rabbit anti-REK7 and immunoblotting with mouse 
anti-phosphotyrosine were essentially as described (Kaplan et al., 
1991a, 1991b). Immunoblotted bands were visualized using a horse- 
radish peroxidase-conjugated sheep anti-mouse antibody and the 
ECL fluorescence detection system (Amersham) as described by the 
manufacturer. 
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